Global Immunity Nutraceutical Ingredient

Immunity Nutraceutical Ingredient Comprehensive Study by Type (Minerals, Omega-3 fatty acids, Carotenoids, Fibers & specialty carbohydrates, Phytochemical and plant extracts, Others), Application (Functional food, Functional beverages, Dietary supplements, Animal nutrition, Personal care) Players and Region - Global Market Outlook to 2027

Immunity Nutraceutical Ingredient Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Immunity Nutraceutical Ingredient Market Overview:
The expansion in life expectancy and health consciousness among consumers, as well as the increased use of nutraceutical components, are driving the global Nutraceutical Ingredients Market. Furthermore, the convenience of product availability through online retail platforms is expected to boost demand for nutraceutical products, boosting the Nutraceutical Ingredients Market.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • Increasing Demand for Fortified Food Owing to the Rising Health Consciousness among People
  • Mandates on Food Fortification by Government Organizations

Roadblocks
  • Higher Costs of Fortified Products Preventing Large-Scale Usage

Opportunities
  • Increase in Life Hope And Health Consciousness Among Consumers
  • Growing Demand for Functional and Fortified Foods

Challenges
  • Consumer Skepticism Associated with Nutraceutical Products


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (United States), Ajinomoto Co., Inc. (Japan), Arla Foods (Denmark), Tate & Lyle PLC (United Kingdom), Cargill (United States), Archer Daniels Midland Company (United States), BASF SE (Germany), Associated British Foods (United Kingdom) and Ingreidon (United States). Analyst at AMA Research see Global Players to retain maximum share of Global Immunity Nutraceutical Ingredient market by 2027.

Latest Market Insights:
On August 21, 2020, Zystus Nutraceuticals has launched its immunity boosters Zys-Co-Vir and Zys-Co-Min formulated as per the recommendation of the Union AYUSH Ministry to boost immunity against Covid-19.

On 03 Mar 2021, Royal DSM announced the launch of ampli-D®, a fast-acting form of vitamin D for dietary supplements in Australia. ampli-D® is a faster and more effective way for Australian consumers to boost vitamin D levels in the body in just days and weeks instead of months to support immune health.

What Can be Explored with the Immunity Nutraceutical Ingredient Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Immunity Nutraceutical Ingredient Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Immunity Nutraceutical Ingredient
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Immunity Nutraceutical Ingredient market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Immunity Nutraceutical Ingredient market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts And Strategic Business Planners, Immunity Nutraceutical Ingredients Provider, Venture Capitalists And Private Equity Firms, Government Regulatory And Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Minerals
  • Omega-3 fatty acids
  • Carotenoids
  • Fibers & specialty carbohydrates
  • Phytochemical and plant extracts
  • Others
By Application
  • Functional food
  • Functional beverages
  • Dietary supplements
  • Animal nutrition
  • Personal care
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Fortified Food Owing to the Rising Health Consciousness among People
      • 3.2.2. Mandates on Food Fortification by Government Organizations
    • 3.3. Market Challenges
      • 3.3.1. Consumer Skepticism Associated with Nutraceutical Products
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations in the Immunity Nutraceutical Ingredient Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunity Nutraceutical Ingredient, by Type, Application and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Immunity Nutraceutical Ingredient (Value)
      • 5.2.1. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 5.2.1.1. Minerals
        • 5.2.1.2. Omega-3 fatty acids
        • 5.2.1.3. Carotenoids
        • 5.2.1.4. Fibers & specialty carbohydrates
        • 5.2.1.5. Phytochemical and plant extracts
        • 5.2.1.6. Others
      • 5.2.2. Global Immunity Nutraceutical Ingredient by: Application (Value)
        • 5.2.2.1. Functional food
        • 5.2.2.2. Functional beverages
        • 5.2.2.3. Dietary supplements
        • 5.2.2.4. Animal nutrition
        • 5.2.2.5. Personal care
      • 5.2.3. Global Immunity Nutraceutical Ingredient Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Immunity Nutraceutical Ingredient (Price)
      • 5.3.1. Global Immunity Nutraceutical Ingredient by: Type (Price)
  • 6. Immunity Nutraceutical Ingredient: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Koninklijke DSM N.V. (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ingredion Incorporated (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ajinomoto Co., Inc. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arla Foods (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Tate & Lyle PLC (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cargill (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Archer Daniels Midland Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BASF SE (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Associated British Foods (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ingreidon (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunity Nutraceutical Ingredient Sale, by Type, Application and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Immunity Nutraceutical Ingredient (Value)
      • 7.2.1. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 7.2.1.1. Minerals
        • 7.2.1.2. Omega-3 fatty acids
        • 7.2.1.3. Carotenoids
        • 7.2.1.4. Fibers & specialty carbohydrates
        • 7.2.1.5. Phytochemical and plant extracts
        • 7.2.1.6. Others
      • 7.2.2. Global Immunity Nutraceutical Ingredient by: Application (Value)
        • 7.2.2.1. Functional food
        • 7.2.2.2. Functional beverages
        • 7.2.2.3. Dietary supplements
        • 7.2.2.4. Animal nutrition
        • 7.2.2.5. Personal care
      • 7.2.3. Global Immunity Nutraceutical Ingredient Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Immunity Nutraceutical Ingredient (Price)
      • 7.3.1. Global Immunity Nutraceutical Ingredient by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 2. Immunity Nutraceutical Ingredient Minerals , by Region USD Million (2016-2021)
  • Table 3. Immunity Nutraceutical Ingredient Omega-3 fatty acids , by Region USD Million (2016-2021)
  • Table 4. Immunity Nutraceutical Ingredient Carotenoids , by Region USD Million (2016-2021)
  • Table 5. Immunity Nutraceutical Ingredient Fibers & specialty carbohydrates , by Region USD Million (2016-2021)
  • Table 6. Immunity Nutraceutical Ingredient Phytochemical and plant extracts , by Region USD Million (2016-2021)
  • Table 7. Immunity Nutraceutical Ingredient Others , by Region USD Million (2016-2021)
  • Table 8. Immunity Nutraceutical Ingredient: by Application(USD Million)
  • Table 9. Immunity Nutraceutical Ingredient Functional food , by Region USD Million (2016-2021)
  • Table 10. Immunity Nutraceutical Ingredient Functional beverages , by Region USD Million (2016-2021)
  • Table 11. Immunity Nutraceutical Ingredient Dietary supplements , by Region USD Million (2016-2021)
  • Table 12. Immunity Nutraceutical Ingredient Animal nutrition , by Region USD Million (2016-2021)
  • Table 13. Immunity Nutraceutical Ingredient Personal care , by Region USD Million (2016-2021)
  • Table 14. South America Immunity Nutraceutical Ingredient, by Country USD Million (2016-2021)
  • Table 15. South America Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 16. South America Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 17. Brazil Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 18. Brazil Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 19. Argentina Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 20. Argentina Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 21. Rest of South America Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 22. Rest of South America Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 23. Asia Pacific Immunity Nutraceutical Ingredient, by Country USD Million (2016-2021)
  • Table 24. Asia Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 25. Asia Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 26. China Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 27. China Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 28. Japan Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 29. Japan Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 30. India Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 31. India Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 32. South Korea Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 33. South Korea Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 34. Taiwan Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 35. Taiwan Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 36. Australia Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 37. Australia Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 38. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 39. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 40. Europe Immunity Nutraceutical Ingredient, by Country USD Million (2016-2021)
  • Table 41. Europe Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 42. Europe Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 43. Germany Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 44. Germany Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 45. France Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 46. France Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 47. Italy Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 48. Italy Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 49. United Kingdom Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 50. United Kingdom Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 51. Netherlands Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 52. Netherlands Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 53. Rest of Europe Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 54. Rest of Europe Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 55. MEA Immunity Nutraceutical Ingredient, by Country USD Million (2016-2021)
  • Table 56. MEA Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 57. MEA Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 58. Middle East Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 59. Middle East Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 60. Africa Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 61. Africa Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 62. North America Immunity Nutraceutical Ingredient, by Country USD Million (2016-2021)
  • Table 63. North America Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 64. North America Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 65. United States Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 66. United States Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 67. Canada Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 68. Canada Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 69. Mexico Immunity Nutraceutical Ingredient, by Type USD Million (2016-2021)
  • Table 70. Mexico Immunity Nutraceutical Ingredient, by Application USD Million (2016-2021)
  • Table 71. Immunity Nutraceutical Ingredient: by Type(USD/Units)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 83. Immunity Nutraceutical Ingredient Minerals , by Region USD Million (2022-2027)
  • Table 84. Immunity Nutraceutical Ingredient Omega-3 fatty acids , by Region USD Million (2022-2027)
  • Table 85. Immunity Nutraceutical Ingredient Carotenoids , by Region USD Million (2022-2027)
  • Table 86. Immunity Nutraceutical Ingredient Fibers & specialty carbohydrates , by Region USD Million (2022-2027)
  • Table 87. Immunity Nutraceutical Ingredient Phytochemical and plant extracts , by Region USD Million (2022-2027)
  • Table 88. Immunity Nutraceutical Ingredient Others , by Region USD Million (2022-2027)
  • Table 89. Immunity Nutraceutical Ingredient: by Application(USD Million)
  • Table 90. Immunity Nutraceutical Ingredient Functional food , by Region USD Million (2022-2027)
  • Table 91. Immunity Nutraceutical Ingredient Functional beverages , by Region USD Million (2022-2027)
  • Table 92. Immunity Nutraceutical Ingredient Dietary supplements , by Region USD Million (2022-2027)
  • Table 93. Immunity Nutraceutical Ingredient Animal nutrition , by Region USD Million (2022-2027)
  • Table 94. Immunity Nutraceutical Ingredient Personal care , by Region USD Million (2022-2027)
  • Table 95. South America Immunity Nutraceutical Ingredient, by Country USD Million (2022-2027)
  • Table 96. South America Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 97. South America Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 98. Brazil Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 99. Brazil Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 100. Argentina Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 101. Argentina Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 102. Rest of South America Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 103. Rest of South America Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 104. Asia Pacific Immunity Nutraceutical Ingredient, by Country USD Million (2022-2027)
  • Table 105. Asia Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 106. Asia Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 107. China Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 108. China Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 109. Japan Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 110. Japan Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 111. India Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 112. India Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 113. South Korea Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 114. South Korea Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 115. Taiwan Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 116. Taiwan Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 117. Australia Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 118. Australia Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 119. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 120. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 121. Europe Immunity Nutraceutical Ingredient, by Country USD Million (2022-2027)
  • Table 122. Europe Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 123. Europe Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 124. Germany Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 125. Germany Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 126. France Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 127. France Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 128. Italy Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 129. Italy Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 130. United Kingdom Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 131. United Kingdom Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 132. Netherlands Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 133. Netherlands Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 134. Rest of Europe Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 135. Rest of Europe Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 136. MEA Immunity Nutraceutical Ingredient, by Country USD Million (2022-2027)
  • Table 137. MEA Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 138. MEA Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 139. Middle East Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 140. Middle East Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 141. Africa Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 142. Africa Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 143. North America Immunity Nutraceutical Ingredient, by Country USD Million (2022-2027)
  • Table 144. North America Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 145. North America Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 146. United States Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 147. United States Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 148. Canada Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 149. Canada Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 150. Mexico Immunity Nutraceutical Ingredient, by Type USD Million (2022-2027)
  • Table 151. Mexico Immunity Nutraceutical Ingredient, by Application USD Million (2022-2027)
  • Table 152. Immunity Nutraceutical Ingredient: by Type(USD/Units)
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunity Nutraceutical Ingredient: by Type USD Million (2016-2021)
  • Figure 5. Global Immunity Nutraceutical Ingredient: by Application USD Million (2016-2021)
  • Figure 6. South America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 7. Asia Pacific Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 8. Europe Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 9. MEA Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 10. North America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 11. Global Immunity Nutraceutical Ingredient: by Type USD/Units (2016-2021)
  • Figure 12. Global Immunity Nutraceutical Ingredient share by Players 2021 (%)
  • Figure 13. Global Immunity Nutraceutical Ingredient share by Players (Top 3) 2021(%)
  • Figure 14. Global Immunity Nutraceutical Ingredient share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Koninklijke DSM N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 17. Koninklijke DSM N.V. (Netherlands) Revenue: by Geography 2021
  • Figure 18. Ingredion Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 19. Ingredion Incorporated (United States) Revenue: by Geography 2021
  • Figure 20. Ajinomoto Co., Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Ajinomoto Co., Inc. (Japan) Revenue: by Geography 2021
  • Figure 22. Arla Foods (Denmark) Revenue, Net Income and Gross profit
  • Figure 23. Arla Foods (Denmark) Revenue: by Geography 2021
  • Figure 24. Tate & Lyle PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Tate & Lyle PLC (United Kingdom) Revenue: by Geography 2021
  • Figure 26. Cargill (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cargill (United States) Revenue: by Geography 2021
  • Figure 28. Archer Daniels Midland Company (United States) Revenue, Net Income and Gross profit
  • Figure 29. Archer Daniels Midland Company (United States) Revenue: by Geography 2021
  • Figure 30. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 31. BASF SE (Germany) Revenue: by Geography 2021
  • Figure 32. Associated British Foods (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Associated British Foods (United Kingdom) Revenue: by Geography 2021
  • Figure 34. Ingreidon (United States) Revenue, Net Income and Gross profit
  • Figure 35. Ingreidon (United States) Revenue: by Geography 2021
  • Figure 36. Global Immunity Nutraceutical Ingredient: by Type USD Million (2022-2027)
  • Figure 37. Global Immunity Nutraceutical Ingredient: by Application USD Million (2022-2027)
  • Figure 38. South America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 39. Asia Pacific Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 40. Europe Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 41. MEA Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 42. North America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 43. Global Immunity Nutraceutical Ingredient: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Koninklijke DSM N.V. (Netherlands)
  • Ingredion Incorporated (United States)
  • Ajinomoto Co., Inc. (Japan)
  • Arla Foods (Denmark)
  • Tate & Lyle PLC (United Kingdom)
  • Cargill (United States)
  • Archer Daniels Midland Company (United States)
  • BASF SE (Germany)
  • Associated British Foods (United Kingdom)
  • Ingreidon (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 221 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Immunity Nutraceutical Ingredient Quantitative research analysis
Global Immunity Nutraceutical Ingredient Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Immunity Nutraceutical Ingredient market are Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (United States), Ajinomoto Co., Inc. (Japan), Arla Foods (Denmark), Tate & Lyle PLC (United Kingdom), Cargill (United States), Archer Daniels Midland Company (United States), BASF SE (Germany), Associated British Foods (United Kingdom) and Ingreidon (United States), to name a few.
"Technological Innovations in the Immunity Nutraceutical Ingredient Industry" is seen as one of major influencing trends for Immunity Nutraceutical Ingredient Market during projected period 2021-2027.
Minerals segment in Global market to hold robust market share owing to "Increasing Demand for Fortified Food Owing to the Rising Health Consciousness among People ".
dominated the Immunity Nutraceutical Ingredient market. This is attributable to growing trend of "Technological Innovations in the Immunity Nutraceutical Ingredient Industry"

Know More About Global Immunity Nutraceutical Ingredient Report?

Have a Query? Click Here

Other Related Reports

Tuberculin Syringe Comprehensive Study by Type (Tuberculin Syringe with Permanently Attached Needle, Tuberculin Syringes with Detachable Needle), Application (Hospital , Clinic , Others), Distributio...
$ 3650
Medical Mattress Comprehensive Study by Type (Foam, Innerspring, Air, Water), Application (Hospital, Clinic, Home Care, Others), Distribution Channel (Online, Offline), Material Type (Bamboo/Cotton, ...
$ 3350
Medical Gloves Comprehensive Study by Type (Examination, Surgical, Chemotherapy), Application (Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Rehabilitation Centers, Others), Usa...
$ 3750
Needleless Syringe Comprehensive Study by Type (Jet Injectors, Inhaler Technology, Transdermal Patch, Novel Needle Free Technologies), Application (Vaccine Delivery, Pain Management, Insulin Delivery...
$ 3450
Oxaliplatin Comprehensive Study by Type (Mannitol, Glucose Solution, Lactose Solution, Others), Application (Colorectal Cancer (XELOX), Pancreatic Cancer, Gastroesophageal Cancer, Testicular Cancer, ...
$ 3450
Bacterial Vaginosis Drug Comprehensive Study by Type (Rx, OTC), Application (Hospital, Pharmacy, Others), End Users (Hospital, Pharmacy, Other) Players and Region - Global Market Outlook to 2027
$ 3500